BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 15893270)

  • 1. Feasibility report for retreatment of locally recurrent head-and-neck cancers by combined brachy-chemotherapy using frameless image-guided 3D interstitial brachytherapy.
    Krempien RC; Grehn C; Haag C; Straulino A; Hensley FW; Kotrikova B; Hofele C; Debus J; Harms W
    Brachytherapy; 2005; 4(2):154-62. PubMed ID: 15893270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
    Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
    Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.
    Strnad V; Geiger M; Lotter M; Sauer R
    Brachytherapy; 2003; 2(3):158-63. PubMed ID: 15062138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reirradiation of locally recurrent nasopharyngeal carcinoma.
    Lengyel E; Baricza K; Somogyi A; Olajos J; Pápai Z; Godény M; Németh G; Esik O
    Strahlenther Onkol; 2003 May; 179(5):298-305. PubMed ID: 12740656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer.
    Pellizzon AC; dos Santos Novaes PE; Conte Maia MA; Ferrigno R; Fogarolli R; Salvajoli JV; Kowalski LP
    Head Neck; 2005 Dec; 27(12):1035-41. PubMed ID: 16114005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
    Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
    Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies.
    Kramer NM; Horwitz EM; Cheng J; Ridge JA; Feigenberg SJ; Cohen RB; Nicolaou N; Sherman EJ; Babb JS; Damsker JA; Langer CJ
    Head Neck; 2005 May; 27(5):406-14. PubMed ID: 15719391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results.
    Dimopoulos JC; Kirisits C; Petric P; Georg P; Lang S; Berger D; Pötter R
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):83-90. PubMed ID: 16839702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
    Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical organ preservation in reirradiation brachytherapy by injectable spacer.
    Kishi K; Sonomura T; Shirai S; Sato M; Tanaka K
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):587-94. PubMed ID: 19735885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck.
    Spencer SA; Harris J; Wheeler RH; Machtay M; Schultz C; Spanos W; Rotman M; Meredith R; Ang KK
    Head Neck; 2008 Mar; 30(3):281-8. PubMed ID: 17764087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Planned post-chemoradiation neck dissection: significance of radiation dose.
    Stenson KM; Huo D; Blair E; Cohen EE; Argiris A; Haraf DJ; Vokes EE
    Laryngoscope; 2006 Jan; 116(1):33-6. PubMed ID: 16481805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
    Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.
    Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM
    Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy.
    Kolotas C; Tselis N; Sommerlad M; Röddiger S; Schnabel T; Baltas D; Kalogera-Fountzila A; Fountzilas G; Zamboglou N
    Strahlenther Onkol; 2007 Feb; 183(2):69-75. PubMed ID: 17294110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.